Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists. 2011

Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
Tsukuba Research Institute, Banyu Pharmaceutical Co. Ltd, Japan.

The design, synthesis and structure-activity relationships of a novel class of N-phenylpyridone MCH1R antagonists are described. The core part of the N-phenylpyridone structure was newly designed and the side chain moieties that were attached to the core part were extensively explored. As a result of optimization of the N-phenylpyridone leads, we successfully developed the orally available, and brain-penetrable MCH1R selective antagonist 7c, exhibiting excellent anti-obese effect in diet-induced obese (DIO) mice.

UI MeSH Term Description Entries
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017481 Receptors, Somatostatin Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behavior of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin's role as a neurotransmitter. Receptors, Somatotropin Release Inhibiting Hormone,Somatostatin Receptors,Receptors, SRIH,SRIH Receptors,Somatostatin Receptor,Receptor, Somatostatin
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
August 2009, Bioorganic & medicinal chemistry letters,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
August 2013, Bioorganic & medicinal chemistry letters,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
September 2010, ChemMedChem,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
January 2009, Bioorganic & medicinal chemistry letters,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
June 2009, Bioorganic & medicinal chemistry letters,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
July 2006, Bioorganic & medicinal chemistry letters,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
September 2014, Bioorganic & medicinal chemistry letters,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
April 2010, Bioorganic & medicinal chemistry letters,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
January 2005, Bioorganic & medicinal chemistry letters,
Yuji Haga, and Sayaka Mizutani, and Akira Naya, and Hiroyuki Kishino, and Hisashi Iwaasa, and Masahiko Ito, and Junko Ito, and Minoru Moriya, and Nagaaki Sato, and Norihiro Takenaga, and Akane Ishihara, and Shigeru Tokita, and Akio Kanatani, and Norikazu Ohtake
August 2012, Journal of medicinal chemistry,
Copied contents to your clipboard!